(Q36042262)

11 August 2017

1 reference

title

Adiponectin: a relevant player in PPARgamma-agonist-mediated improvements in hepatic insulin sensitivity? (English)

1 reference

11 August 2017

1 reference

Bouskila M

1

1 reference

11 August 2017

Pajvani UB

series ordinal

2

1 reference

11 August 2017

Scherer PE

series ordinal

3

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

International Journal of Obesity

11 August 2017

published in

1 reference

11 August 2017

volume

29 Suppl 1

1 reference

11 August 2017

page(s)

S17-23

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.ijo.0802908

11 August 2017

exact match

0 references

cites work

Global and societal implications of the diabetes epidemic

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802908

New drug targets for type 2 diabetes and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802908

Treating diabetes using oral agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802908

The mechanisms of action of PPARs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802908

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802908

Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802908

Peroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802908

PPARgamma : a nuclear regulator of metabolism, differentiation, and cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802908

Troglitazone Antagonizes Tumor Necrosis Factor-α-induced Reprogramming of Adipocyte Gene Expression by Inhibiting the Transcriptional Regulatory Functions of NF-κB

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802908

Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802908

Effect of thiazolidinediones on body weight in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802908

Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802908

Muscle-specific Pparg deletion causes insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802908

Muscle-specific PPARgamma-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802908

Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802908

Targeted elimination of peroxisome proliferator-activated receptor gamma in beta cells leads to abnormalities in islet mass without compromising glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802908

Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802908

Minireview: The adipocyte--at the crossroads of energy homeostasis, inflammation, and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802908

Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802908

Endogenous glucose production is inhibited by the adipose-derived protein Acrp30

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802908

A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802908

The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802908

Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802908

Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802908

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802908

Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802908

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802908

Adiponectin and leptin levels in HIV-infected subjects with insulin resistance and body fat redistribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802908

AdipoQ is a novel adipose-specific gene dysregulated in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802908

The adipocyte-secreted protein Acrp30 enhances hepatic insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802908

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802908

Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802908

A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802908

Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802908

PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802908

Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802908

Differential regulation of adipocytokine mRNAs by rosiglitazone in db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802908

Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802908

The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802908

Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802908

Studies on antidiabetic agents. II. Synthesis of 5-[4-(1-methylcyclohexylmethoxy)-benzyl]thiazolidine-2,4-dione (ADD-3878) and its derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802908

7 January 2021

Studies on antidiabetic agents. I. Synthesis of 5-[4-(2-methyl-2-phenylpropoxy)-benzyl]thiazolidine-2,4-dione (AL-321) and related compounds

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802908

7 January 2021

Studies on antidiabetic agents. III. 5-Arylthiazolidine-2,4-diones as potent aldose reductase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802908

7 January 2021

Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802908

7 January 2021

Weight Reduction Increases Plasma Levels of an Adipose-Derived Anti-Inflammatory Protein, Adiponectin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802908

7 January 2021

Identifiers

DOI

10.1038/SJ.IJO.0802908

1 reference

11 August 2017

1 reference